Abnova Taiwan Valuation
| 4133 Stock | TWD 30.25 0.10 0.33% |
At this time, the firm appears to be overvalued. Abnova Taiwan Corp shows a prevailing Real Value of NT$25.25 per share. The current price of the firm is NT$30.25. Our model approximates the value of Abnova Taiwan Corp from analyzing the firm fundamentals such as Profit Margin of 0.15 %, current valuation of 2.11 B, and Return On Equity of 0.0505 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Abnova Taiwan's price fluctuation is very steady at this time. Calculation of the real value of Abnova Taiwan Corp is based on 3 months time horizon. Increasing Abnova Taiwan's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Abnova stock is determined by what a typical buyer is willing to pay for full or partial control of Abnova Taiwan Corp. Since Abnova Taiwan is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Abnova Stock. However, Abnova Taiwan's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 30.25 | Real 25.25 | Hype 30.25 | Naive 30.95 |
The intrinsic value of Abnova Taiwan's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Abnova Taiwan's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Abnova Taiwan Corp helps investors to forecast how Abnova stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Abnova Taiwan more accurately as focusing exclusively on Abnova Taiwan's fundamentals will not take into account other important factors: Abnova Taiwan Total Value Analysis
Abnova Taiwan Corp is presently anticipated to have takeover price of 2.11 B with market capitalization of 2.3 B, debt of 18.4 M, and cash on hands of 171.86 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Abnova Taiwan fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.11 B | 2.3 B | 18.4 M | 171.86 M |
Abnova Taiwan Investor Information
About 22.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.98. In the past many companies with similar price-to-book ratios have beat the market. Abnova Taiwan Corp last dividend was issued on the 16th of June 2022. The entity had 1030:1000 split on the 28th of August 2017. Based on the analysis of Abnova Taiwan's profitability, liquidity, and operating efficiency, Abnova Taiwan Corp is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Abnova Taiwan Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Abnova Taiwan has an asset utilization ratio of 35.19 percent. This indicates that the Company is making NT$0.35 for each dollar of assets. An increasing asset utilization means that Abnova Taiwan Corp is more efficient with each dollar of assets it utilizes for everyday operations.Abnova Taiwan Ownership Allocation
Abnova Taiwan holds a total of 60.55 Million outstanding shares. Abnova Taiwan Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Abnova Taiwan Profitability Analysis
The company reported the revenue of 451.49 M. Net Income was 28.37 M with profit before overhead, payroll, taxes, and interest of 197.34 M.About Abnova Taiwan Valuation
Our relative valuation model uses a comparative analysis of Abnova Taiwan. We calculate exposure to Abnova Taiwan's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Abnova Taiwan's related companies.Abnova Corporation manufactures and sells various recombinant proteins and antibodies. Abnova Corporation is headquartered in Taipei, Taiwan. ABNOVA CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
8 Steps to conduct Abnova Taiwan's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Abnova Taiwan's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Abnova Taiwan's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Abnova Taiwan's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Abnova Taiwan's revenue streams: Identify Abnova Taiwan's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Abnova Taiwan's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Abnova Taiwan's growth potential: Evaluate Abnova Taiwan's management, business model, and growth potential.
- Determine Abnova Taiwan's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Abnova Taiwan's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Abnova Stock Analysis
When running Abnova Taiwan's price analysis, check to measure Abnova Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abnova Taiwan is operating at the current time. Most of Abnova Taiwan's value examination focuses on studying past and present price action to predict the probability of Abnova Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abnova Taiwan's price. Additionally, you may evaluate how the addition of Abnova Taiwan to your portfolios can decrease your overall portfolio volatility.